Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation
Background: The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an indicator of a systemic inflammatory response. There are baseline differences in the inflammation status between paroxysmal atrial fibrillation (PAF) and persistent AF (PerAF). The NLR changes and late recurrences of AF (LR...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906720303626 |
_version_ | 1818952706340945920 |
---|---|
author | Masamichi Yano Yasuyuki Egami Kohei Ukita Akito Kawamura Hitoshi Nakamura Yutaka Matsuhiro Koji Yasumoto Masaki Tsuda Naotaka Okamoto Akihiro Tanaka Yasuharu Matsunaga-Lee Ryu Shutta Masami Nishino Jun Tanouchi |
author_facet | Masamichi Yano Yasuyuki Egami Kohei Ukita Akito Kawamura Hitoshi Nakamura Yutaka Matsuhiro Koji Yasumoto Masaki Tsuda Naotaka Okamoto Akihiro Tanaka Yasuharu Matsunaga-Lee Ryu Shutta Masami Nishino Jun Tanouchi |
author_sort | Masamichi Yano |
collection | DOAJ |
description | Background: The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an indicator of a systemic inflammatory response. There are baseline differences in the inflammation status between paroxysmal atrial fibrillation (PAF) and persistent AF (PerAF). The NLR changes and late recurrences of AF (LRAF) after ablation depending on the AF type remain unknown. Methods: Consecutive AF patients undergoing pulmonary vein isolation (PVI) by radiofrequency catheter ablation were enrolled from September 2014 to June 2018. The peripheral blood leukocyte NLR 1 day before and 36–48 h after PVI were measured. First, the relationship between NLR changes after to before ablation (ΔNLR) and ERAFs/LRAFs in PAF and PerAF patients were investigated to exclude the baseline inflammation status and evaluate catheter ablation induced inflammation. Second, the clinical impact of the NLR for predicting LRAFs was evaluated. Results: There hundred sixty-nine PAF and 264 PerAF patients from Osaka Rosai AF registry were enrolled. The ratio of ERAFs/LRAFs in PAF and PerAF patients were 26.8%/22.5% and 39.4%/29.9%, respectively. In PAF and PerAF patients, the ΔNLR was significantly higher with ERAF than no-ERAF (p = 0.022 and p = 0.010, respectively). In PAF patients, the ΔNLR was significantly higher with LRAF than no-LRAF (p = 0.017), while with PerAF, the ΔNLR did not significantly differ between LRAFs and no-LRAFs. In PAF, the ΔNLR was independently and significantly associated with LRAFs after PVI (p = 0.029). Conclusion: The ΔNLR was significantly higher only in PAF patients with LRAFs than no-LRAFs, but not in PerAF patients. The ΔNLR was useful for predicting LRAFs after PVI in PAF patients. |
first_indexed | 2024-12-20T09:54:38Z |
format | Article |
id | doaj.art-68451bac76444dfe9430c70eea24d719 |
institution | Directory Open Access Journal |
issn | 2352-9067 |
language | English |
last_indexed | 2024-12-20T09:54:38Z |
publishDate | 2020-12-01 |
publisher | Elsevier |
record_format | Article |
series | International Journal of Cardiology: Heart & Vasculature |
spelling | doaj.art-68451bac76444dfe9430c70eea24d7192022-12-21T19:44:29ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672020-12-0131100664Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablationMasamichi Yano0Yasuyuki Egami1Kohei Ukita2Akito Kawamura3Hitoshi Nakamura4Yutaka Matsuhiro5Koji Yasumoto6Masaki Tsuda7Naotaka Okamoto8Akihiro Tanaka9Yasuharu Matsunaga-Lee10Ryu Shutta11Masami Nishino12Jun Tanouchi13Division of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanCorresponding author.; Division of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanDivision of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, JapanBackground: The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an indicator of a systemic inflammatory response. There are baseline differences in the inflammation status between paroxysmal atrial fibrillation (PAF) and persistent AF (PerAF). The NLR changes and late recurrences of AF (LRAF) after ablation depending on the AF type remain unknown. Methods: Consecutive AF patients undergoing pulmonary vein isolation (PVI) by radiofrequency catheter ablation were enrolled from September 2014 to June 2018. The peripheral blood leukocyte NLR 1 day before and 36–48 h after PVI were measured. First, the relationship between NLR changes after to before ablation (ΔNLR) and ERAFs/LRAFs in PAF and PerAF patients were investigated to exclude the baseline inflammation status and evaluate catheter ablation induced inflammation. Second, the clinical impact of the NLR for predicting LRAFs was evaluated. Results: There hundred sixty-nine PAF and 264 PerAF patients from Osaka Rosai AF registry were enrolled. The ratio of ERAFs/LRAFs in PAF and PerAF patients were 26.8%/22.5% and 39.4%/29.9%, respectively. In PAF and PerAF patients, the ΔNLR was significantly higher with ERAF than no-ERAF (p = 0.022 and p = 0.010, respectively). In PAF patients, the ΔNLR was significantly higher with LRAF than no-LRAF (p = 0.017), while with PerAF, the ΔNLR did not significantly differ between LRAFs and no-LRAFs. In PAF, the ΔNLR was independently and significantly associated with LRAFs after PVI (p = 0.029). Conclusion: The ΔNLR was significantly higher only in PAF patients with LRAFs than no-LRAFs, but not in PerAF patients. The ΔNLR was useful for predicting LRAFs after PVI in PAF patients.http://www.sciencedirect.com/science/article/pii/S2352906720303626Atrial fibrillationRecurrencePulmonary vein isolationInflammationNeutrophil-to-lymphocyte ratio |
spellingShingle | Masamichi Yano Yasuyuki Egami Kohei Ukita Akito Kawamura Hitoshi Nakamura Yutaka Matsuhiro Koji Yasumoto Masaki Tsuda Naotaka Okamoto Akihiro Tanaka Yasuharu Matsunaga-Lee Ryu Shutta Masami Nishino Jun Tanouchi Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation International Journal of Cardiology: Heart & Vasculature Atrial fibrillation Recurrence Pulmonary vein isolation Inflammation Neutrophil-to-lymphocyte ratio |
title | Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
title_full | Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
title_fullStr | Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
title_full_unstemmed | Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
title_short | Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
title_sort | atrial fibrillation type modulates the clinical predictive value of neutrophil to lymphocyte ratio for atrial fibrillation recurrence after catheter ablation |
topic | Atrial fibrillation Recurrence Pulmonary vein isolation Inflammation Neutrophil-to-lymphocyte ratio |
url | http://www.sciencedirect.com/science/article/pii/S2352906720303626 |
work_keys_str_mv | AT masamichiyano atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT yasuyukiegami atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT koheiukita atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT akitokawamura atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT hitoshinakamura atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT yutakamatsuhiro atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT kojiyasumoto atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT masakitsuda atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT naotakaokamoto atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT akihirotanaka atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT yasuharumatsunagalee atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT ryushutta atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT masaminishino atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation AT juntanouchi atrialfibrillationtypemodulatestheclinicalpredictivevalueofneutrophiltolymphocyteratioforatrialfibrillationrecurrenceaftercatheterablation |